Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel (Medical News Today) PDF Print

Rules-Based Medicine, Inc. (RBM), the world's leading multiplexed biomarker testing laboratory, announced the launch of its Human Kidney Multi-Analyte Profile (MAP), a cost-effective biomarker testing service designed to aid pharmaceutical and biotechnology companies in their efforts to improve drug development through better understanding of drug toxicity.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.